Quick viewing(Text Mode)

The Coxiella Burnetii Qph1 Plasmid Is a Virulence Factor for Colonizing

The Coxiella Burnetii Qph1 Plasmid Is a Virulence Factor for Colonizing

bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by ) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

1 The Coxiella burnetii QpH1 plasmid is a factor for

2 colonizing bone marrow-derived murine macrophages

3

4 Shengdong Luo1,2¶, Zhihui Sun2¶, Huahao Fan1¶, Shanshan Lu1,3&, Yan Hu3&,

5 Ruisheng Li3&, Xiaoping An1&, Yigang Tong1*, Lihua Song1,2*

6

7 1 Beijing Advanced Innovation Center for Soft Matter Science and Engineering, 8 College of Life Science and Technology, Beijing University of Chemical Technology, 9 Beijing, China 10 11 2 State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of 12 and Epidemiology, Beijing, China 13 14 3 Research Center for Clinical Medicine, The Fifth Medical Center of PLA General 15 Hospital, Beijing, China 16

17 * Corresponding author

18 Email: [email protected] (LS); [email protected] (YT).

19

20 ¶ These authors contributed equally to this work.

21 & These authors also contributed equally to this work.

22 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

23 Abstract

24 Coxiella burnetii carries a large conserved plasmid or plasmid-like chromosomally

25 integrated sequence of unknown function. Here we report the curing of QpH1 plasmid

26 from C. burnetii Nine Mile phase II, the characterization of QpH1-deficient C.

27 burnetii in in vitro and in vivo models, and the characterization of plasmid

28 biology. A shuttle vector pQGK, which is composed of the CBUA0036-0039a region

29 (predicted for QpH1 maintenance), an E. coli plasmid ori, eGFP and kanamycin

30 resistance genes was constructed. The pQGK vector can be stably transformed into

31 Nine Mile II and maintained at a similar low copy like QpH1. Importantly,

32 transformation with pQGK cured the endogenous QpH1 due to plasmid

33 incompatibility. Compared to a Nine Mile II transformant of a RSF1010-based vector,

34 the pQGK transformant shows an identical one-step growth curve in axenic media, a

35 similar growth curve in Buffalo green monkey kidney cells, an evident growth defect

36 in macrophage-like THP-1 cells, and dramatically reduced ability of colonizing bone

37 marrow-derived murine macrophages. In the SCID mouse infection model, the pQGK

38 transformants caused a lesser extent of splenomegaly. Moreover, the plasmid biology

39 was investigated by mutagenesis. We found CBUA0037-0039 are essential for

40 plasmid maintenance, and CBUA0037-0038 account for plasmid compatibility. Taken

41 together, our data suggest that QpH1 encodes factor(s) essential for colonizing murine

42 macrophages, and to a lesser extent for colonizing human macrophages. This study

43 highlights a critical role of QpH1 for C. burnetii persistence in rodents, and expands

44 the toolkit for genetic studies in C. burnetii.

45

46 Author summary bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

47 It is postulated that C. burnetii recently evolved from an inherited symbiont of ticks

48 by the acquisition of novel virulence factors. All C. burnetii isolates carry a large

49 plasmid or have a chromosomally integrated plasmid-like sequence. The plasmid is a

50 candidate virulence factor that contributes to C. burnetii evolution. Here we describe

51 the construction of novel shuttle vectors that allow to make plasmid-deficient C.

52 burnetii mutants. With this plasmid-curing approach, we characterized the role of the

53 QpH1 plasmid in in vitro and in vivo C. burnetii infection models. We found that the

54 plasmid plays a critical role for C. burnetii growth in macrophages, especially in

55 murine macrophages, but not in axenic media and BGMK cells. Our work highlights

56 an essential role of the plasmid for the acquisition of colonizing capability in rodents

57 by C. burnetii. This study represents a major step toward unravelling the mystery of

58 the C. burnetii cryptic plasmids.

59

60 Introduction

61 C. burnetii is a Gram-negative intracellular bacterium that causes Q fever, a world

62 widely distributed zoonosis [1]. It is highly infectious and is classified as a potential

63 biowarfare agent [2]. Its in humans are mostly asymptomatic but may

64 manifest as an acute disease (mainly as a self-limiting febrile illness, pneumonia, or

65 hepatitis) or as a chronic disease (mainly endocarditis in patients with previous

66 valvulopathy) [1]. All C. burnetii isolates maintain a large cryptic plasmid or

67 plasmid-like chromosomally integrated sequence [3]. This absolute conservation of

68 plasmid sequences suggests they are critical in C. burnetii survival [4]. Increased

69 knowledge of the plasmid sequences will enhance our understanding of C. burnetii

70 biology and pathogenesis and will be important for guiding the design of live bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

71 attenuated vaccine strains for the prevention of Q fever.

72 C. burnetii has at least five different plasmid types: four different plasmids

73 (QpH1, QpRS, QpDV, and QpDG) and one type of QpRS-like chromosomally

74 integrated sequence [5-9]. The plasmids range from 32 to 54 kb in size and share a 25

75 kb core region [3]. Characterization of these plasmid types led to the classification of

76 five associated genomic groups. The hypothesized correlation of plasmid types and

77 genomic groups with the clinical outcomes of Q fever was controversial [3, 10, 11],

78 but the concept of genomic-group specific virulence was supported by mouse and

79 guinea pig infection studies [12, 13]. According to studies on C. burnetii mostly from

80 Europe and North America, this bacterium is considered having a clonal population

81 structure with low genetic diversity [14-16]. Future studies on more C. burnetii

82 isolates especially from other regions will help to understand its global genetic

83 diversity.

84 The sequences of all five representative plasmid types in C. burnetii have been

85 determined [3, 7, 8, 17, 18]. Paul et al. analyzed the diversity of plasmid genes by

86 using DNA microarrays [3]. Nine predicted functional plasmid ORFs are conserved in

87 all plasmid sequences. Two of these ORFs appear to encode proteins similar to phage

88 proteins involved in tail assembly and site-specific recombination, while seven of

89 them encode hypothetical proteins. Three (CBUA0006, -0013 and -0023) of these

90 conserved plasmid hypothetical proteins are secreted effectors of the type IV secretion

91 system [4]. During ectopic expression in HeLa cells, these effectors localize at

92 different subcellular sites, suggesting roles in subversion of host cell functions. In

93 addition, novel plasmid-specific effectors were also identified, supporting the concept

94 of pathotype virulence [19]. Besides the identification of plasmid-encoded secretion

95 effectors, the plasmid is also speculated to be able to be transferred to the host cell bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

96 [20].

97 The advent and foregoing improvement of axenic culture techniques greatly

98 facilitates studies on C. burnetii biology [21-24]. C. burnetii replicates within

99 phagolysosome-like parasitophorous vacuoles (termed Coxiella-containing vacuole,

100 or CCV) in mononuclear phagocytes. Genetic studies revealed that the CCV

101 biogenesis and C. burnetii growth in host cells require a type IV secretion system and

102 a repertoire of type IV effectors [25-28]. The role that these effectors play in C.

103 burnetii pathogenicity is of intense interest. However, regarding the plasmid effectors,

104 reports on their mutants are scarce. By using transposon mutagenesis, Martinez et al.

105 identified mutants of eight QpH1 genes and observed strong phenotypes with mutants

106 of parB and repA, surprisingly, not the mutant of the conserved secretion effector

107 CBUA0023 [29]. Regardless of the identification of plasmid secretion effectors, a role

108 for the plasmid in C. burnetii pathogenesis remains elusive.

109 Since the first development of axenic media, the C. burnetii genetics toolbox has

110 been expanding [30, 31]. Current genetic tools for C. burnetii include, but are not

111 limited to, transposon systems [32], RSF1010 ori-based shuttle vectors [4, 33] and

112 targeted gene inactivation systems [31]. However, there have been no reports of

113 studies using these tools to decipher roles of plasmids in C. burnetii pathogenesis.

114 Here, we describe a set of QpH1-derived shuttle vectors for C. burnetii transformation.

115 These shuttle vectors have different compatibilities with QpH1 and different

116 stabilities in C. burnetii. A QpH1-deficient strain of C. burnetii was constructed by

117 transforming with the pQGK vector. Infection experiments show that QpH1 is

118 essential for colonizing bone marrow-derived murine macrophages. This work

119 increases our knowledge on plasmid biology and provides new genetic tools for

120 investigating C. burnetii pathogenesis. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

121

122 Results

123 C. burnetii plasmid has a putative iteron-like origin of replication

124 The QpH1 plasmid of the Nine Mile isolate is 37,319-bp in size and encodes 40 ORFs,

125 of which only 11 are similar to proteins of known function (Figure 1A) [18]. Besides

126 its cryptic role in pathogenesis, the plasmid’s mechanism of replication and

127 partitioning also lacks investigation. A gene cluster CBUA0036-39 encodes homologs

128 of ParB, ParA, RepB and RepA, respectively, which are supposed to function in

129 plasmid replication and partitioning based on protein similarities. The plasmid was

130 found to have a low copy number [10], but its origin of replication has never been

131 identified. With equicktandem of the EMBOSS software suite [34, 35], we found a

132 putative origin of replication -a region composed of four 21-bp iteron-like sequences

133 between CBUA0036 and -37 (Figure 1B). Unlike the highly conserved iterons in

134 other plasmids, all four iteron-like sequences in QpH1 have base variations from each

135 other. And in currently known C. burnetii plasmids, this putative iteron region is

136 highly conserved. The finding of this putative iteron region suggests genes required

137 for QpH1 replication and partitioning are clustered.

138

139 Construction of incompatible plasmid pQGK and curing of endogenous QpH1

140 from Nine Mile II by transformation

141 The RSF1010-ori based shuttle vectors are routinely used for C. burnetii

142 transformation [31, 33]. We first made a RSF1010-ori based shuttle vector pMMGK

143 for transformation (Figure 2A). An incompatible plasmid pQGK was then constructed

144 as suggested by the clustering of genes (CBUA0036-39) for QpH1 maintenance bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

145 (Figure 2B). The hypothetical CBUA0039a gene was also incorporated in pQGK, as

146 this gene locates close to CBUA0039 and might play unknown roles in plasmid

147 maintenance. The plasmids -pMMGK and pQGK were transformed into Nine Mile II,

148 respectively. After passaging in the presence of kanamycin for six to seven times, the

149 transformants were cloned by using semi-solid ACCM-2 plates and characterized by

150 PCR detection of QpH1 ORFs. All QpH1 ORFs can be detected in NMIIpMMGK, but

151 only the CBUA0036-39a ORFs can be detected in NMIIpQGK (Figure 3). The

152 absence of CBUA001-0034a in NMIIpQGK indicates that the endogenous QpH1 was

153 cured by transformation of pQGK.

154

155 QpH1-deficient C. burnetii has normal growth kinetics in axenic media and

156 BGMK cells

157 The transformants of pMMGK and pQGK -NMIIpMMGK and NMIIpQGK derived

158 from a same Nine Mile II clone. In addition to carrying different shuttle vectors, their

159 major genetic difference is the presence or absence of the endogenous QpH1 plasmid.

160 Both shuttle vectors carry the eGFP cassette, and their clonal homogeneity was

161 inspected by observing eGFP expression. We investigated the potential impact of

162 QpH1 on bacterial growth with these two eGFP-labeled transformants. Their growth

163 kinetics in ACCM-2 media and BGMK cells were assessed by measuring their

164 one-step growth curves (Figure 4A-B). These two transformants display almost

165 identical growth kinetics, suggesting QpH1 is not important for C. burnetii growth in

166 axenic media and BGMK cells.

167 Interestingly, though having similar growth kinetics, these two transformants

168 differ significantly in their expression of eGFP genes (Figure 5). The eGFP genes of

169 these two transformants have identical promoters, but the fluorescence intensity of bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

170 NMIIpMMGK appears to be higher than that of NMIIpQGK. The difference in level

171 of eGFP expression between these two transformants may reflex the difference in

172 gene copy numbers. The copy number of RSF1010-ori based shuttle vector is 3 to 6,

173 while the QpH1 copy number is between one to three. Our data show that QpH1 and

174 pQGK have a similar copy number, suggesting that pQGK retains all genes for QpH1

175 replication and partitioning. The copy number of pMMGK is about two to three times

176 of the copy number of pQGK, which is consistent with their expression levels of

177 eGFP. Overall, our data suggest the copy number of QpH1 and pQGK is under highly

178 stringent control.

179

180 QpH1-deficient C. burnetii almost completely fails to colonize murine bone

181 marrow derived macrophages

182 In vitro, C. burnetii can infect a variety of cell types including epithelial and fibroblast

183 cell lines. However, this bacterium has an infection tropism for mononuclear

184 phagocytes in natural infections [36]. We next characterized the growth of

185 NMIIpMMGK and NMIIpQGK in human macrophage-like THP-1 cells and murine

186 bone marrow-derived macrophages (murine BMDM) (Figure 6), both of which can

187 support robust growth of C. burnetii phase II under normoxic culture conditions

188 [37-39]. Equal MOIs of NMIIpMMGK and NMIIpQGK were used to infect THP-1

189 and murine BMDM cells.

190 In THP-1 cells (Figure 6A), NMIIpMMGK has robust growth at 96 hours

191 post-infection, as shown by the densely packed bacterial clumps and intensive eGFP

192 expressions in its large CCVs. In contrast, NMIIpQGK CCVs are partially filled with

193 bacterial clumps and have lower eGFP expression. This evident lower growth rate of

194 NMIIpQGK is confirmed in the one-step growth curves of these two strains (Figure bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

195 6B). It is noted that the lower eGFP expression of NMIIpQGK in THP-1 is likely due

196 to a combination of lower plasmid copy number and lower growth rate. In addition,

197 we repeatedly measured a minor lower (p<0.05) number of NMIIpQGK at the

198 infection time point of zero, which is the starting time after bacterial entry (Figure 6B).

199 Overall, these THP-1 infection results suggest that QpH1 plays roles in C. burnetii

200 attachment and multiplication in human macrophages.

201 We next compared the growth of NMIIpMMGK and NMIIpQGK in murine

202 BMDMs. In murine BMDMs at 96 hours post-infection, NMIIpMMGK forms normal

203 CCVs that can be easily observed in any microscope field (Figure 6C). This

204 observation is consistent with previous finding of robust growth of C. burnetii phase

205 II in murine BMDMs [38]. Contrarily, NMIIpQGK produces almost zero CCVs. In

206 our repeated experiments, only one NMIIpQGK CCV was ever observed. This rarely

207 observed CCV of NMIIpQGK is shown in Figure 6C. Consistent with microscope

208 observations, no growth yield of NMIIpQGK is detected by qPCR (Figure 6D). It is

209 noted our growth yields of NMIIpMMGK are not optimal when compared to the

210 report of Cockrell et al [38], which is likely due to our modified infection procedures,

211 such as centrifugation at room temperature instead of 37ºC. In addition, comparison

212 of the GE numbers at the starting time point of infection suggested that NMIIpQGK

213 also has slightly reduced attachment efficiency (p<0.05), which is similar with

214 findings in THP-1. Altogether, the murine BMDM infection results suggest that QpH1

215 is essential for C. burnetii survival in murine macrophages.

216

217 Plasmid-less C. burnetii can be isolated by using CBUA0037 or -0038-deleted

218 shuttle vectors

219 The shuttle plasmid pQGK can be stably maintained and has a normal plasmid copy bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

220 number in C. burnetii Nine Mile phase II. We next investigated the plasmid genes for

221 plasmid maintenance in pQGK. A PCR-based deletion mutagenesis approach was

222 adopted to generate specific deletions in each of the five QpH1 ORFs

223 (CBUA0036-0039, -0039a) (Figure 7A) [40]. The deletion regions range from 60% to

224 100% of these ORFs. Primers with unique restriction enzyme sites at their 5´ ends

225 were used for PCR amplification as described in Materials and Methods. After

226 digestion with restriction enzymes, purified PCR products were ligated and

227 transformed into E. coli Trans5α. The desired plasmid construct was confirmed by

228 sequencing. The plasmid knockout vectors are referred to as pQGK-D1, -D2, -D3, D4

229 and -D5, corresponding to deletion mutants of CBUA0036, -0037, -0038, -0039 and

230 -0039a, respectively.

231 Transformations of C. burnetii Nine Mile phase II with these knockout vectors

232 were performed. All knockout vectors contain the eGFP cassette. Their transformants

233 were cultured in kanamycin media and were constantly observed by using

234 fluorescence microscopy. After several passages, transformants were cloned for three

235 times on semi-solid plates. The cloned transformants were then cultured in kanamycin

236 media. The stability of the transformants was assessed by observing eGFP expression.

237 Transformation results are summarized in Table 1. Stable transformants carrying

238 pQGK-D1 and -D5 were isolated (Figure 7B). PCR detection of QpH1 genes indicate

239 that QpH1 was also cured from these transformants. The results of pQGK-D1 and -D5

240 reveal that CBUA0036 and -0039a are not required for stable plasmid maintenance in

241 axenic culture of C. burnetii.

242 Transformation with other three deletion vectors yielded transient or unstable

243 transformants in the presence of antibiotic selection. For the transformation with

244 pQGK-D4, green fluorescence was observed at the first passage after electroporation, bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

245 but failed to expand in the presence of kanamycin selection. The green fluorescence

246 can be repeatedly observed at the first passages in repeated experiments. This

247 transient eGFP expression suggests that pQGK-D4 was introduced into C. burnetii by

248 electroporation but cannot be stably maintained.

249 Transformation with pQGK-D2 and -D3 produced significant bacterial yields in

250 the presence of kanamycin selection. However, clones from kanamycin plates always

251 give a mixture of eGFP-positive and eGFP-negative bacterial clumps. Further

252 identification of these eGFP negative clones revealed that these clones are double

253 deficient of QpH1 and the deletion mutant of pQGK (Figure 7B-C). This unstable

254 eGFP expression and the obtaining of plasmid-deficient C. burnetii suggest that

255 pQGK-D2 and -D3 are incompatible with QpH1 and their transformants are

256 constantly losing their shuttle plasmid due to partitioning deficiency. A

257 plasmid-deficient C. burnetii clone NMIIp- was isolated by three successive cloning

258 of pQGK-D2 transformants. Altogether, these results show that CBUA0037, -0038

259 and -0039 are essential genes for QpH1 maintenance and the pQGK-D2 and -D3

260 vectors are valuable tools for constructing plasmid-deficient C. burnetii.

261 Table 1. Viability and stability of C. burnetii Nine Mile phase II transformed with

262 five pQGK deletion derivatives

Phenotypes of transformants growing in kanamycin media Plasmid Bacterial growth eGFP stability pQGK-D1 + stable (ΔCBUA0036) pQGK-D2 + unstable (ΔCBUA0037) pQGK-D3 + unstable (ΔCBUA0038) pQGK-D4 - transient (ΔCBUA0039) pQGK-D5 + stable (ΔCBUA0039a) 263 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

264 QpH1-deficient C. burnetii has reduced pathogenicity in SCID mice

265 The SCID mouse model was established for identifying virulence factors in C.

266 burnetii phase II [41]. We next analyzed the plasmid’s potential role in C. burnetii

267 pathogenesis by using this model (Figure 8). Four C. burnetii strains -the parent Nine

268 Mile phase II (NMII) and its three derivatives (NMIIpMMGK, NMIIpQGK and

269 NMIIp-) were used to infect SCID mice by peritoneal (IP) injections. Compared to

270 PBS control group, all four C. burnetii strains induced different levels of

271 splenomegaly in infected mice (Figure 8A-B). However, it is apparent that

272 QpH1-bearing strains (NMII and NMIIpMMGK) induced bigger splenomegaly that

273 QpH1-deficient strains (NMIIpQGK and NMIIp-) (p<0.05), suggesting QpH1 plays a

274 role in pathogenicity. It is noted that NMIIpMMGK has a tendency of causing bigger

275 splenomegaly than its parent NMII (p=0.10), indicative of enhanced virulence by the

276 pMMGK plasmid. This enhanced virulence of NMIIpMMGK is likely associated with

277 this strain’s ability of normoxic growth. Characterization of C. burnetii normoxic

278 growth was described in a separate manuscript [42]. Moreover, the sizes of

279 splenomegaly are in accordance with C. burnetii genome equivalents in all infected

280 mice (Figure 8C). It is also obvious that NMIIpQGK retains partial pathogenicity in

281 SCID mice, which is inexplicable as this strain has lost the ability of infecting mouse

282 BMDMs generated from C57BL/6J. Altogether, our data suggest QpH1 plays a partial

283 role in pathogenicity in the SCID mouse model.

284

285 Discussion

286 All C. burnetii has one of the four different types of plasmids or one plasmid-like

287 chromosomally integrated sequence. The plasmids’ role in C. burnetii biology has

288 been implicated by the identification of type IV secretion effectors [4, 19]. Our goal bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

289 was to construct and characterize plasmid-deficient C. burnetii. We show that

290 QpH1-deficient C. burnetii Nine Mile phase II -NMIIpQGK can be constructed by

291 transformation with a QpH1-based shuttle vector pQGK. The NMIIpQGK strain has

292 normal growth in axenic media and BGMK cells, displays partial growth defects in

293 human macrophages and, most strikingly, shows severe infection-deficiency in mouse

294 BMDMs. In the SCID mouse model, the NMIIpQGK strain has partially reduced

295 pathogenicity. We show that CBUA0037, -0038 and -0039 are essential ORFs for

296 QpH1 maintenance, and unmarked QpH1-deficient mutants can be made by

297 transformation with an unstable CBUA0037, or CBUA0038 deletion shuttle vector.

298 Plasmids are commonly classified by incompatibility (Inc) typing [43]. Plasmids

299 that share the same replication mechanisms are incompatible. The Inc type of C.

300 burnetii plasmids remains to be determined. An incompatible plasmid can be used for

301 making plasmid-deficient C. burnetii strains. Our findings that pQGK can cure the

302 endogenous QpH1 by transformation and has a same copy number of QpH1 indicate

303 that pQGK retains an intact QpH1 replicon including genes for plasmid replication,

304 partitioning and copy number control. The pQGK plasmid can be used for Inc typing

305 of C. burnetii plasmids. The pQGK derivatives -pQGK-D2 or -D3 can be used for

306 making unmarked plasmid-deficient mutants. C. burnetii has four types of plasmids.

307 This plasmid curing approach has potential applications for investigating

308 plasmid-type virulence of C. burnetii.

309 Plasmids can maintain their copy numbers by one of the three general classes of

310 negative regulatory systems [44]. Iterons and their cognate replication (Rep) initiator

311 proteins comprise the iteron-involved negative control system [45]. Our results

312 revealed that QpH1 is of low copy number and has atypical iterons. The replication

313 and copy number control of QpH1 is likely regulated through the iterons-Rep bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

314 complex. Iterons are able to exert plasmid incompatibility [46]. Further studies are

315 required to understand the iterons involved regulation of plasmid replication in C.

316 burnetii. In addition, these iterons’ cognate RepA protein -annotated CBUA0039, is

317 supported by our finding of transient transformation with the pQGK-D4 vector. An

318 AT-rich region, locating between the iterons and CBUA0037, could be another

319 essential element for QpH1 replication [47].

320 QpH1 is a plasmid of low copy number [10]. Low-copy plasmids have an active

321 partitioning system. Two putative partitioning proteins -CBUA0036 (ParB) and -0037

322 (ParA), have been annotated based on protein homology. Our results suggest that

323 CBUA0037 and -0038 are essential partitioning proteins while CBUA0036 is

324 nonessential for plasmid maintenance. The commonly used RSF1010-ori based

325 shuttle vectors for C. burnetii is also used in the genetic studies of Legionella

326 pneumophila [33]. Our identification of essential genes for QpH1 maintenance might

327 be useful for constructing QpH1 based shuttle vectors that can be stably maintained in

328 L. pneumophila.

329 Besides genes for plasmid maintenance (replication, copy number control and

330 partitioning), plasmids from pathogenic microbes often contain genes associated with

331 virulence and/or antibiotic resistance [40]. Three of the 40 QpH1 ORFs are essential

332 for plasmid maintenance. Most of other ORFs likely contribute to C. burnetii

333 virulence in various ways. Our finding of QpH1-deficient C. burnetii failing to

334 colonize murine BMDMs likely explains the high conservation of plasmid genes in C.

335 burnetii. We postulate that C. burnetii plasmids are essential for bacterial survival in

336 natural reservoir hosts, including rodents. The role of rodents as a potential reservoir

337 was suggested by finding C. burnetii infections in mice in different areas and

338 countries [48-50]. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

339 How might plasmid genes contribute to the colonization of murine BMDMs?

340 Previous studies using human cells found that the type IV secretion system and a

341 repertoire of type IV effectors required for the CCV biogenesis and C. burnetii growth

342 [25-28]. The role that these type IV effectors play in C. burnetii pathogenicity is of

343 intense interest [51]. Plasmid encoded effectors are possibly involved in the reduced

344 growth efficiency of QpH1-deficient C. burnetii on THP-1 cells, and might also relate

345 to the failed colonization of murine BMDMs by QpH1-deficient C. burnetii. Newton

346 and co-workers found that effector proteins can be translocated as early as 1 h

347 post-infection in murine BMDMs, while effector translocation can only be detected

348 after 8 h post-infection in HeLa cells [52]. We surmise that early translocation of

349 effectors might play an essential role in C. burnetii resisting antimicrobial activities of

350 murine BMDMs. Further studies to investigate the pathogenesis of plasmid genes

351 required for C. burnetii infection and growth in murine BMDMs are warranted.

352 The QpH1-deficient C. burnetii almost completely abrogates its capacity of

353 infecting murine BMDMs. Thus, it is unexpected that this mutant has only partially

354 reduced its pathogenicity in SCID mice. It is possible that the antimicrobial capacity

355 of macrophages is also dampened in this immunodeficiency mouse model. The

356 immunocompetent animal model with C. burnetii phase I as control may be more

357 appropriate for studying plasmid pathogenesis [12]. It is also unexpected that the

358 pMMGK transformant appears to have enhanced pathogenicity. Though similar with

359 other RSF1010-ori based shuttle vectors, the pMMGK vector confers an unexpected

360 capability of normoxic growth on C. burnetii, which likely relates to the

361 transformant’s enhanced virulence. The normoxic growth of C. burnetii was

362 characterized in a separate manuscript [42].

363 In conclusion, we investigated the functions of C. burnetii QpH1 plasmid genes. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

364 We report that QpH1 is a low copy plasmid. We propose that the intergenic region

365 between CBUA0036 and -0037 is the plasmid’s origin of replication, and the

366 plasmid’s copy number is regulated through atypical iterons within this region. The

367 CBUA0037, -0038 and -0039 ORFs encode two partitioning proteins and Rep

368 proteins, respectively. QpH1 can be cured by transformation with pQGK or its two

369 derivatives (pQGK-D2 and -D3). We present evidence that QpH1 is nonessential for

370 C. burnetii growth in axenic media and BGMK cells. QpH1-deficient C. burnetii

371 phase II has minor growth deficiency in human macrophages. Most importantly, we

372 found QpH1 is essential for C. burnetii colonization of murine BMDMs, highlighting

373 an important role of the plasmid for C. burnetii persistence in rodents. It is certain that

374 more plasmid related phenotypes remain to be identified. Our shuttle vectors will

375 further the progress of genetic studies of C. burnetii and its plasmids. This work

376 represents an important step toward unravelling the mystery of plasmid conservation

377 in C. burnetii.

378

379 Methods

380 Bacterial strains, cell lines and key reagents

381 C. burnetii Nine Mile phase II (NM II) is from our laboratory strain collection and

382 was passaged in ACCM-2 as previously described [22]. E. coli Trans5α (TransGen

383 Biotech) was used for recombinant DNA procedures and was grown in Luria-Bertan

384 (LB) media. Buffalo green monkey kidney cells (BGMK) were grown in RPMI 1640

385 medium supplemented with 10% FBS. Human monocytic leukemia cells (THP-1)

386 were cultured in high-glucose-containing Dulbecco’s Modified Eagle Medium

387 (DMEM) supplemented with 10% FBS. Murine bone marrow-derived macrophages

388 (BMDM) were generated from C57BL/6J female mice as described by Cockrell et al bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

389 [38]. Primers used in this study are listed in S1 Table. Escherichia coli Trans5α

390 (TransGen Biotech) was used for all plasmid amplification.

391

392 Construction of a RSF1010 ori-based shuttle vector pMMGK

393 RSF1010 ori-based shuttle vectors are commonly used for C. burnetii transformation

394 [30, 33]. We constructed a RSF1010 ori-based vector pMMGK based on the backbone

395 of pMMB207 (kindly provided by Xuehong Zhang from Shanghai Jiaotong

396 University, Shanghai, China). Promoter regions of CBU0311 and CBU1169 were

397 amplified with primer pairs P311-F/P311-R and P1169- F/P1169-R, respectively. The

398 KanR and eGFP genes were amplified from pEASY-T1 and pEGFP-C1, with primer

399 pairs Kan-F/Kan-R and eGFP-F/eGFP-R, respectively. Overlapping PCR with primers

400 P311-F/Kan-R was used to produce the P311-eGFP-P1169-KanR segment. Two

401 segments -pUC ori and ampicillin resistance gene (AmpR) were amplified from

402 pEASY-T1 with primer pairs pUC-F/pUC-R and Amp-F/Amp-R, respectively.

403 Overlapping PCR with primers P311-F/pUC-R was used to produce the

404 P311-eGFP-P1169-KanR-pUC ori segment. This segment and the AmpR-containing

405 segment were digested with Nhe I and Xho I, and ligated to generate the vector pAGK.

406 The RSF1010 backbone and the P311-eGFP-P1169-KanR segment were amplified

407 from pMMB207 and pAGK, with primer pairs RSF1010-F/RSF1010-R and

408 P311-F/KAN-R, respectively, then were digested with Nhe I and Xho I and ligated to

409 generate the shuttle vector pMMGK (S2 Appendix).

410

411 Construction of C. burnetii QpH1-based shuttle vector pQGK

412 The shuttle vector pQGK was constructed by replacing the AmpR region of pAGK

413 with a predicted region for plasmid replication and partitioning in QpH1. Briefly, a bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

414 5.6-kb segment covering CBUA0036-39a was amplified with primers pQ-F and pQ-R.

415 PCR amplifications were performed in 100-μl reaction volumes containing 50 ng

416 DNA, a 0.2 mM concentration of each dNTP, a 0.2 μM concentration of each primer,

417 2.5 U TransStart FastPfu DNA polymerase (TransGen Biotech), and 20 μl buffer. PCR

418 conditions were as follows: initial denaturation at 95°C for 4 min followed by 2

419 cycles of amplification at 95°C for 30s, 55°C for 30s and 72°C for 1 min every two kb

420 and then 28 cycles of amplification at 95°C 30s, 57°C for 30s and 72°C for 1 min

421 every two kb and a final extension at 72°C for 10 min. This QpH1 segment and the

422 pAGK plasmid were digested with Nhe I and Xho I and ligated to produce the shuttle

423 plasmid pQGK (S3 Appendix).

424

425 Construction of deletion derivatives of pQGK

426 Deletion derivative of pQGK were constructed using a modified PCR-based approach

427 [40]. Primers pairs for knocking out CBUA0036-39a were shown in Table S1 in the

428 supplemental material. Briefly, PCR amplifications were performed using TransStart

429 FastPfu DNA polymerase (TransGen Biotech) and PCR conditions were described as

430 above. PCR products were purified by a QIAquick PCR purification kit (Qiagen) and

431 doubly digested with DMT (to remove template DNA, TransGen Biotech) and

432 restriction enzymes as indicated. Digested PCR products were ligated using Quick T4

433 DNA ligase (NEB) and transformed into E. coli Trans5α. Clones were screened for

434 plasmids containing QpH1 ORFs but lacking the deleted region by PCR.

435

436 Transformation of C. burnetii Nine Mile phase II

437 All plasmids used in this study were purified using a plasmid Maxi Kit (Qiagen) and

438 subjected to sequencing confirmation. The resulting vector was transformed into C. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

439 burnetii Nine Mile phase II by electroporation [31]. For every passage after

440 electroporation, C. burnetii was cultured at 2.5% O2 and 5% CO2 for seven days in

441 ACCM-2 containing 400 μg/mL kanamycin. Fluorescence microscopy was conducted

442 to check eGFP expression after each passage. When eGFP expression was easily

443 observed in bacterial clumps, semi-solid agarose plates were then used for three

444 successive cloning. C. burnetii transformants were expanded in ACCM-2, suspended

445 in SPG (0.25M sucrose, 10mM sodium phosphate, 5mM L-glutamic acid) and kept

446 frozen at -80ºC. Genome copy numbers were determined by Taqman probe qPCR

447 specific to dotA [53].

448

449 PCR identification of transformants

450 The presence or absence of QpH1 in C. burnetii transformants were detected by PCR.

451 Total DNAs were extracted using DNeasy blood & tissue kit (Qiagen), then used as

452 templates for PCR detection with TransTaq high fidelity DNA polymerase (TransGen)

453 and QpH1 gene primers (S4 Table). PCR conditions are as follows: initial

454 denaturation at 94ºC for 5 min, followed by 35 cycles of 94ºC for 30 s, 55ºC for 30 s,

455 72ºC for 90 s.

456

457 One-step growth curves

458 To measure the one-step growth curves in axenic media, seed stocks of C. burnetii

459 was inoculated at a density of 2×106 GE/ml in 96-well plates containing 150 μl

460 ACCM-2 medium per well. Cultures were incubated in a CO-170 tri-gas incubator at

461 37°C with 2.5% O2 and 5% CO2. Samples of axenic culture were collected at

462 indicated time points, then were centrifuged at 20,000 g for 10 min to harvest

463 bacteria. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

464 To measure the one-step growth curves in cells, seed stocks of C. burnetii was

465 plated onto 24-well cell (BGMK, THP-1 and BMDM) monolayers at an MOI of 50.

466 Then, 24-well plates were centrifuged at 800 g for 25 min at room temperature, placed

467 in a CO2 incubator (5% CO2) at 37ºC for 2 hours. Cells were then washed twice with

468 PBS and 1 ml cell medium was added to each well. At indicated time, cell samples

469 were harvested by using trypsin (Hyclone) treatment and centrifugation.

470 Total DNAs were extracted with DNeasy Blood Tissue Kit (Qiagen). Genome

471 copy numbers of C. burnetii in both axenic and cell cultures were determined by

472 Taqman probe qPCR as previously described [53]. PCR conditions were as follows:

473 initial denaturation at 94ºC for 10min, followed by 40 cycles of amplification at 94ºC

474 for 15 s, 60ºC for 1min. All samples were performed in quadruplicate.

475

476 SCID mice infections

477 SCID (CB17/Icr-Prkdcscid/IcrlcoCrl) mice were purchased from Vital River

478 Laboratory Animal Technology Co., Ltd (Beijing, China). Freshly cultured C. burnetii

479 and its transformants –NMIIp-, NMIIpMMGK and NMIIpQGK were diluted to 5×107

480 GE/mL in PBS. Six six-week old female mice per group were infected with 1×107 GE

481 C. burnetii in 200 μl PBS via intra-peritoneal injection. At 18 days postinfection,

482 hearts, lungs, livers, and spleens were aseptically harvested and stored at -80°C,

483 additionally, spleens were weighted to determine splenomegaly (spleen weight/body

484 weight). All samples were individually added up to 2 mL with PBS and homogenized

485 using a glass grinder. DNAs were purified from 20 μL tissue homogenate with

486 DNeasy Blood Tissue Kit (Qiagen) and were used to determine C. burnetii GE by

487 qPCR as described above. All animal experimental procedures involved were

488 performed according to protocols approved by the Institutional Animal Care and Use bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

489 Committee of Fifth Medical Center, General Hospital of Chinese PLA. The project

490 ethics review approval number is IACUC-2018-0020.

491

492 Acknowledgments

493 This work was supported by National Natural Science Foundation of China (No.

494 31570177), Fundamental Research Funds for Central Universities (No.

495 BUCTRC201917), Key Project of Beijing University of Chemical Technology (No.

496 XK1803-06) and Foundation of State Key Laboratory of Pathogen and Biosecurity

497 (No. SKLPBS1409).

498

499 References

500 1. Maurin M, Raoult D. Q fever. Clin Microbiol Rev. 1999; 12(4): 518-53. PubMed

501 PMID: 10515901; PubMed Central PMCID: PMC88923.

502 2. Atlas RM. Bioterrorism and biodefence research: changing the focus of

503 microbiology. Nat Rev Microbiol. 2003; 1(1): 70-4. Epub 2004/03/26. doi:

504 10.1038/nrmicro728. PubMed PMID: 15040182.

505 3. Beare PA, Samuel JE, Howe D, Virtaneva K, Porcella SF, Heinzen RA. Genetic

506 diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-based

507 whole-genome comparisons. J Bacteriol. 2006; 188(7): 2309-24. doi:

508 10.1128/JB.188.7.2309-2324.2006. PubMed PMID: 16547017; PubMed Central

509 PMCID: PMC1428397.

510 4. Voth DE, Beare PA, Howe D, Sharma UM, Samoilis G, Cockrell DC, et al. The

511 Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion

512 system substrates. J Bacteriol. 2011; 193(7): 1493-503. doi: 10.1128/JB.01359-10.

513 PubMed PMID: 21216993; PubMed Central PMCID: PMC3067651. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

514 5. Thiele D, Willems H, Haas M, Krauss H. Analysis of the entire nucleotide

515 sequence of the cryptic plasmid QpH1 from Coxiella burnetti. Eur J Epidemiol.

516 1994; 10(4): 413-20. PubMed PMID: 7843345.

517 6. Valkova D, Kazar J. A new plasmid (QpDV) common to Coxiella burnetii

518 isolates associated with acute and chronic Q fever. FEMS Microbiol Lett. 1995;

519 125(2-3): 275-80. PubMed PMID: 7875575.

520 7. Willems H, Ritter M, Jager C, Thiele D. Plasmid-homologous sequences in the

521 chromosome of plasmidless Coxiella burnetii Scurry Q217. J Bacteriol. 1997;

522 179(10): 3293-7. PubMed PMID: 9150226; PubMed Central PMCID:

523 PMC179109.

524 8. Lautenschlager S, Willems H, Jager C, Baljer G. Sequencing and characterization

525 of the cryptic plasmid QpRS from Coxiella burnetii. Plasmid. 2000; 44(1): 85-8.

526 doi: 10.1006/plas.2000.1470. PubMed PMID: 10873529.

527 9. Jager C, Lautenschlager S, Willems H, Baljer G. Coxiella burnetii plasmid types

528 QpDG and QpH1 are closely related and likely identical. Vet Microbiol. 2002;

529 89(2-3): 161-6. PubMed PMID: 12243893.

530 10. Samuel JE, Frazier ME, Mallavia LP. Correlation of plasmid type and disease

531 caused by Coxiella burnetii. Infect Immun. 1985; 49(3): 775-9. PubMed PMID:

532 4030104; PubMed Central PMCID: PMC261272.

533 11. Thiele D, Willems H. Is plasmid based differentiation of Coxiella burnetii in

534 'acute' and 'chronic' isolates still valid? Eur J Epidemiol. 1994; 10(4): 427-34.

535 PubMed PMID: 7843346.

536 12. Long CM, Beare PA, Cockrell DC, Larson CL, Heinzen RA. Comparative

537 virulence of diverse Coxiella burnetii strains. Virulence. 2019; 10(1): 133-50.

538 Epub 2019/02/21. doi: 10.1080/21505594.2019.1575715. PubMed PMID: bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

539 30782062; PubMed Central PMCID: PMCPMC6389282.

540 13. Russell-Lodrigue KE, Andoh M, Poels MW, Shive HR, Weeks BR, Zhang GQ, et

541 al. Coxiella burnetii isolates cause genogroup-specific virulence in mouse and

542 guinea pig models of acute Q fever. Infect Immun. 2009; 77(12): 5640-50. doi:

543 10.1128/IAI.00851-09. PubMed PMID: 19786560; PubMed Central PMCID:

544 PMC2786457.

545 14. Hornstra HM, Priestley RA, Georgia SM, Kachur S, Birdsell DN, Hilsabeck R, et

546 al. Rapid typing of Coxiella burnetii. PloS one. 2011; 6(11): e26201. doi:

547 10.1371/journal.pone.0026201. PubMed PMID: 22073151; PubMed Central

548 PMCID: PMC3206805.

549 15. Hemsley CM, O'Neill PA, Essex-Lopresti A, Norville IH, Atkins TP, Titball RW.

550 Extensive genome analysis of Coxiella burnetii reveals limited evolution within

551 genomic groups. BMC Genomics. 2019; 20(1): 441. Epub 2019/06/06. doi:

552 10.1186/s12864-019-5833-8. PubMed PMID: 31164106; PubMed Central

553 PMCID: PMCPMC6549354.

554 16. Stein A, Saunders NA, Taylor AG, Raoult D. Phylogenic homogeneity of

555 Coxiella burnetii strains as determinated by 16S ribosomal RNA sequencing.

556 FEMS Microbiol Lett. 1993; 113(3): 339-44. PubMed PMID: 7505761.

557 17. Beare PA, Jeffrey BM, Martens CA, Heinzen RA. Draft genome sequences of the

558 avirulent Coxiella burnetii Dugway 7D77-80 and Dugway 7E65-68 strains

559 isolated from rodents in Dugway, Utah. Genome Announc. 2017; 5(39). doi:

560 10.1128/genomeA.00984-17. PubMed PMID: 28963209; PubMed Central

561 PMCID: PMCPMC5624755.

562 18. Seshadri R, Paulsen IT, Eisen JA, Read TD, Nelson KE, Nelson WC, et al.

563 Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc Natl bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

564 Acad Sci U S A. 2003; 100(9): 5455-60. doi: 10.1073/pnas.0931379100. PubMed

565 PMID: 12704232; PubMed Central PMCID: PMC154366.

566 19. Maturana P, Graham JG, Sharma UM, Voth DE. Refining the plasmid-encoded

567 Type IV secretion system substrate repertoire of Coxiella burnetii. J Bacteriol.

568 2013; 195(14): 3269-76. doi: 10.1128/JB.00180-13. PubMed PMID: 23687269;

569 PubMed Central PMCID: PMC3697647.

570 20. Guzman-Herrador DL, Steiner S, Alperi A, Gonzalez-Prieto C, Roy CR, Llosa M.

571 DNA delivery and genomic integration into mammalian target cells through type

572 IV A and B secretion systems of human pathogens. Front Microbiol. 2017; 8:

573 1503. doi: 10.3389/fmicb.2017.01503. PubMed PMID: 28878740; PubMed

574 Central PMCID: PMCPMC5572225.

575 21. Omsland A, Cockrell DC, Howe D, Fischer ER, Virtaneva K, Sturdevant DE, et

576 al. Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc Natl

577 Acad Sci U S A. 2009; 106(11): 4430-4. doi: 10.1073/pnas.0812074106. PubMed

578 PMID: 19246385; PubMed Central PMCID: PMC2657411.

579 22. Omsland A, Beare PA, Hill J, Cockrell DC, Howe D, Hansen B, et al. Isolation

580 from animal tissue and genetic transformation of Coxiella burnetii are facilitated

581 by an improved axenic growth medium. Appl Environ Microbiol. 2011; 77(11):

582 3720-5. doi: 10.1128/AEM.02826-10. PubMed PMID: 21478315; PubMed

583 Central PMCID: PMC3127619.

584 23. Sandoz KM, Beare PA, Cockrell DC, Heinzen RA. Complementation of arginine

585 auxotrophy for genetic transformation of Coxiella burnetii by use of a defined

586 axenic medium. Appl Environ Microbiol. 2016; 82(10): 3042-51. doi:

587 10.1128/AEM.00261-16. PubMed PMID: 26969695.

588 24. Vallejo Esquerra E, Yang H, Sanchez SE, Omsland A. Physicochemical and bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

589 nutritional requirements for axenic replication suggest physiological basis for

590 Coxiella burnetii niche restriction. Front Cell Infect Microbiol. 2017; 7: 190.

591 Epub 2017/06/18. doi: 10.3389/fcimb.2017.00190. PubMed PMID: 28620582;

592 PubMed Central PMCID: PMCPMC5449765.

593 25. Beare PA, Gilk SD, Larson CL, Hill J, Stead CM, Omsland A, et al. Dot/Icm type

594 IVB secretion system requirements for Coxiella burnetii growth in human

595 macrophages. mBio. 2011; 2(4): e00175-11. doi: 10.1128/mBio.00175-11.

596 PubMed PMID: 21862628; PubMed Central PMCID: PMC3163939.

597 26. Carey KL, Newton HJ, Luhrmann A, Roy CR. The Coxiella burnetii Dot/Icm

598 system delivers a unique repertoire of type IV effectors into host cells and is

599 required for intracellular replication. PLoS Pathog. 2011; 7(5): e1002056. doi:

600 10.1371/journal.ppat.1002056. PubMed PMID: 21637816; PubMed Central

601 PMCID: PMC3102713.

602 27. Newton HJ, Kohler LJ, McDonough JA, Temoche-Diaz M, Crabill E, Hartland

603 EL, et al. A Screen of Coxiella burnetii mutants reveals important roles for

604 Dot/Icm effectors and host autophagy in vacuole biogenesis. PLoS Pathog. 2014;

605 10(7): e1004286. doi: 10.1371/journal.ppat.1004286. PubMed PMID: 25080348;

606 PubMed Central PMCID: PMC4117601.

607 28. Kohler LJ, Roy CR. Biogenesis of the lysosome-derived vacuole containing

608 Coxiella burnetii. Microbes Infect. 2015. doi: 10.1016/j.micinf.2015.08.006.

609 PubMed PMID: 26327296.

610 29. Martinez E, Cantet F, Fava L, Norville I, Bonazzi M. Identification of OmpA, a

611 Coxiella burnetii protein involved in host cell invasion, by multi-phenotypic

612 high-content screening. PLoS Pathog. 2014; 10(3): e1004013. doi:

613 10.1371/journal.ppat.1004013. PubMed PMID: 24651569. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

614 30. Beare PA. Genetic manipulation of Coxiella burnetii. Adv Exp Med Biol. 2012;

615 984: 249-71. doi: 10.1007/978-94-007-4315-1_13. PubMed PMID: 22711636.

616 31. Beare PA, Heinzen RA. Gene inactivation in Coxiella burnetii. Methods Mol Biol.

617 2014; 1197: 329-45. doi: 10.1007/978-1-4939-1261-2_19. PubMed PMID:

618 25172290.

619 32. Beare PA, Sandoz KM, Omsland A, Rockey DD, Heinzen RA. Advances in

620 genetic manipulation of obligate intracellular bacterial pathogens. Front

621 Microbiol. 2011; 2: 97. doi: 10.3389/fmicb.2011.00097. PubMed PMID:

622 21833334; PubMed Central PMCID: PMC3153054.

623 33. Chen C, Banga S, Mertens K, Weber MM, Gorbaslieva I, Tan Y, et al. Large-scale

624 identification and translocation of type IV secretion substrates by Coxiella

625 burnetii. Proc Natl Acad Sci U S A. 2010; 107(50): 21755-60. doi:

626 10.1073/pnas.1010485107. PubMed PMID: 21098666; PubMed Central PMCID:

627 PMC3003115.

628 34. Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open

629 Software Suite. Trends Genet. 2000; 16(6): 276-7. Epub 2000/05/29. PubMed

630 PMID: 10827456.

631 35. Sarachu M, Colet M. wEMBOSS: a web interface for EMBOSS. Bioinformatics.

632 2005; 21(4): 540-1. Epub 2004/09/25. doi: 10.1093/bioinformatics/bti031.

633 PubMed PMID: 15388516.

634 36. Voth DE, Heinzen RA. Lounging in a lysosome: the intracellular lifestyle of

635 Coxiella burnetii. Cell Microbiol. 2007; 9(4): 829-40. doi:

636 10.1111/j.1462-5822.2007.00901.x. PubMed PMID: 17381428.

637 37. Ghigo E, Capo C, Tung CH, Raoult D, Gorvel JP, Mege JL. Coxiella burnetii

638 survival in THP-1 monocytes involves the impairment of phagosome maturation: bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

639 IFN-gamma mediates its restoration and bacterial killing. J Immunol. 2002;

640 169(8): 4488-95. PubMed PMID: 12370385.

641 38. Cockrell DC, Long CM, Robertson SJ, Shannon JG, Miller HE, Myers L, et al.

642 Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived

643 murine macrophages. PloS one. 2017; 12(3): e0173528. doi:

644 10.1371/journal.pone.0173528. PubMed PMID: 28278296.

645 39. Hayek I, Fischer F, Schulze-Luehrmann J, Dettmer K, Sobotta K, Schatz V, et al.

646 Limitation of TCA cycle intermediates represents an oxygen-independent

647 nutritional antibacterial effector mechanism of macrophages. Cell Rep. 2019;

648 26(13): 3502-10 e6. Epub 2019/03/28. doi: 10.1016/j.celrep.2019.02.103.

649 PubMed PMID: 30917307.

650 40. Song L, Carlson JH, Whitmire WM, Kari L, Virtaneva K, Sturdevant DE, et al.

651 Chlamydia trachomatis Plasmid-Encoded Pgp4 Is a Transcriptional Regulator of

652 Virulence-Associated Genes. Infect Immun. 2013; 81(3): 636-44. Epub

653 2013/01/16. doi: 10.1128/IAI.01305-12. PubMed PMID: 23319558.

654 41. van Schaik EJ, Case ED, Martinez E, Bonazzi M, Samuel JE. The SCID Mouse

655 Model for Identifying Virulence Determinants in Coxiella burnetii. Front Cell

656 Infect Microbiol. 2017; 7: 25. doi: 10.3389/fcimb.2017.00025. PubMed PMID:

657 28217558; PubMed Central PMCID: PMC5289997.

658 42. Shengdong Luo, Zemin He, Zhihui Sun, Yonghui Yu, Yongqiang Jiang, Yigang

659 Tong, Lihua Song. Culture under normoxic conditions and enhanced virulence of

660 phase II Coxiella burnetii transformed with a RSF1010-based shuttle vector. doi:

661 10.1101/747220.

662 43. Couturier M, Bex F, Bergquist PL, Maas WK. Identification and classification of

663 bacterial plasmids. Microbiol Rev. 1988; 52(3): 375-95. Epub 1988/09/01. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

664 PubMed PMID: 3054468; PubMed Central PMCID: PMCPMC373151.

665 44. del Solar G, Espinosa M. Plasmid copy number control: an ever-growing story.

666 Mol Microbiol. 2000; 37(3): 492-500. Epub 2000/08/10. doi:

667 10.1046/j.1365-2958.2000.02005.x. PubMed PMID: 10931343.

668 45. Chattoraj DK. Control of plasmid DNA replication by iterons: no longer

669 paradoxical. Mol Microbiol. 2000; 37(3): 467-76. Epub 2000/08/10. doi:

670 10.1046/j.1365-2958.2000.01986.x. PubMed PMID: 10931340.

671 46. Rawlings DE, Tietze E. Comparative biology of IncQ and IncQ-like plasmids.

672 Microbiol Mol Biol Rev. 2001; 65(4): 481-96, table of contents. Epub 2001/12/01.

673 doi: 10.1128/MMBR.65.4.481-496.2001. PubMed PMID: 11729261; PubMed

674 Central PMCID: PMCPMC99038.

675 47. Rajewska M, Wegrzyn K, Konieczny I. AT-rich region and repeated sequences -

676 the essential elements of replication origins of bacterial replicons. FEMS

677 Microbiol Rev. 2012; 36(2): 408-34. Epub 2011/11/19. doi:

678 10.1111/j.1574-6976.2011.00300.x. PubMed PMID: 22092310.

679 48. El-Mahallawy HS, Lu G, Kelly P, Xu D, Li Y, Fan W, et al. Q fever in China: a

680 systematic review, 1989-2013. Epidemiol Infect. 2015; 143(4): 673-81. doi:

681 10.1017/S0950268814002593. PubMed PMID: 25274488.

682 49. Stoenner HG, Lackman DB. The biologic properties of Coxiella burnetii isolated

683 from rodents collected in Utah. Am J Hyg. 1960; 71: 45-51. PubMed PMID:

684 13834767.

685 50. Liu L, Baoliang X, Yingqun F, Ming L, Yu Y, Yong H, et al. Coxiella burnetii in

686 rodents on Heixiazi Island at the Sino-Russian border. Am J Trop Med Hyg. 2013;

687 88(4): 770-3. doi: 10.4269/ajtmh.12-0580. PubMed PMID: 23382172; PubMed

688 Central PMCID: PMC3617867. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

689 51. Cunha LD, Ribeiro JM, Fernandes TD, Massis LM, Khoo CA, Moffatt JH, et al.

690 Inhibition of inflammasome activation by Coxiella burnetii type IV secretion

691 system effector IcaA. Nat Commun. 2015; 6: 10205. doi: 10.1038/ncomms10205.

692 PubMed PMID: 26687278; PubMed Central PMCID: PMC4703858.

693 52. Newton HJ, McDonough JA, Roy CR. Effector protein translocation by the

694 Coxiella burnetii Dot/Icm type IV secretion system requires endocytic maturation

695 of the pathogen-occupied vacuole. PLoS One. 2013; 8(1): e54566. doi:

696 10.1371/journal.pone.0054566. PubMed PMID: 23349930; PubMed Central

697 PMCID: PMC3547880.

698 53. Wang T, Yu Y, Liang X, Luo S, He Z, Sun Z, et al. Lipid A Has Significance for

699 optimal growth of Coxiella burnetii in macrophage-like THP-1 cells and to a

700 lesser extent in axenic media and non-phagocytic cells. Front Cell Infect

701 Microbiol. 2018; 8: 192. doi: 10.3389/fcimb.2018.00192. PubMed PMID:

702 29938202; PubMed Central PMCID: PMCPMC6002510.

703

704 Supporting information

705 S1 Table. Primers for plasmids construction.

706 S2 Appendix. Complete sequence of the pMMGK plasmid.

707 S3 Appendix. Complete sequence of the pQGK plasmid

708 S4 Table. Primers for PCR Identification.

709

710 Figure Legends

711 Figure 1. Map of the QpH1 plasmid (A) and the sequence of its predicted origin

712 of replication, which is composed of four 21-bp iteron-like sequences (B). bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

713 The conserved ORFs (green) [3], predicted ORFs for plasmid maintenance (blue) and

714 predicted ori (red) are as indicated (A). In the iteron alignment (B), dots represent

715 nucleotides that are identical to those in the most upper iteron. The first and last

716 nucleotides in each iteron are given as its position in the complete plasmid.

717

718 Figure 2. Map of two shuttle vectors -pMMGK (A) and pQGK (B).

719 Both vectors share identical KanR and eGFP genes, driven by P1169 and P311

720 promotors, respectively. The inner circle of the pMMGK vector represents the

721 backbone of a RSF1010 ori-based plasmid pMMB207 (A). The inner circle of the

722 pQGK vector represents the fragment from QpH1 (B). The genes and their direction

723 of transcription are represented by the boxes of the outer circle.

724

725 Figure 3. PCR detection of QpH1 ORFs in two transformants -NMIIpMMGK (A)

726 and NMIIpQGK (B).

727 All QpH1 ORFs are present in NMIIpMMGK while only the CBUA0036-0039a

728 ORFs can be detected in NMIIpQGK.

729

730 Figure 4. One-step growth curves of two transformants -NMIIpMMGK (solid line)

731 and NMIIpQGK (dotted line) in axenic media (A) and BGMK cells (B).

732 Growth was quantified by measuring GE. Results of axenic and cell cultures are from

733 six and four separate replicates, respectively.

734

735 Figure 5. Phase and fluorescence microscopy of NMIIpMMGK (A, C) and

736 NMIIpQGK (B, D) in axenic media (A-B) and BGMK cells (C-D).

737 Compared to NMIIpQGK, NMIIpMMGK appears to have higher level of eGFP

738 expression in both axenic media and BGMK cells. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

739

740 Figure 6. Growth of C. burnetii transformants -NMIIpMMGK and NMIIpQGK

741 on macrophage-like THP-1 cells (A, B) and bone marrow-derived murine

742 macrophages (BMDMs) (C, D).

743 (A) In THP-1 cells at 96 hours postinfection, CCVs of NMIIpMMGK have strong

744 eGFP expressions and are filled with bacterial particles while CCVs of NMIIpQGK

745 have weak eGFP expression and have much less bacterial particles. (B) Compared to

746 NMIIpMMGK, NMIIpQGK has lower GEs at the initial attachment and lower growth

747 yields throughout the culture period. (C) In BMDMs, NMIIpMMGK forms

748 normal-sized CCVs and has strong eGFP expression while NMIIpQGK almost

749 completely fails to colonize. A rarely observed CCV of NMIIpQGK is shown. (D) In

750 BMDMs, the GEs of NMIIpMMGK increased close to two logs while the GEs of

751 NMIIpQGK have no significant growth throughout the culture period.

752

753 Figure 7. Construction of five individual QpH1 ORF knockout vectors and PCR

754 identification of their transformants.

755 (A) Schematic representation of deleted regions (white) of pQGK in five individual

756 QpH1 ORF knockout vectors. The coding sequences of CBUA0036-0039a and their

757 direction of transcription are shown by the arrows on the line. (B) The CBUA0006

758 ORF is absent in transformants of pQGK, -D1, -D2, -D3, -D5, suggesting these

759 transformants are QpH1-deficient. The CBUA0039 ORF is also absent in

760 transformants of pQGK-D2 and -D3, suggesting these two transformants contain no

761 any plasmid. (C) The CBUA0036-0039a ORFs are absent in NMIIpQGK-D2 and

762 NMIIpQGK-D3, but present in NMIIpQGK.

763 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.

764 Figure 8. Splenomegaly of SCID mouse livers after intra-peritoneal challenge

765 with C. burnetii.

766 SCID mice were challenged with PBS or 1×107 GE of C. burnetii via intra-peritoneal

767 route and sacrificed 18 days after challenge. (A) Spleens were removed from control

768 and challenged mice. (B) Splenomegaly calculated as spleen weight as a percentage

769 of total body weight at the time of necropsy. (C) Genome equivalents calculated using

770 TaqMan real-time PCR with DNA purified from infected spleens from 6 mice on 18

771 days after challenge with C. burnetii. For all panels, error bars represent standard

772 deviations from the mean.

773 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.22.001875; this version posted March 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.